Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,142,000 | 39,924,000 | 10,648,000 | 5,172,000 | 4,897,000 |
| Marketable Securities | N/A | N/A | 0 | 244,000 | 331,000 |
| Receivables | 6,362,000 | 5,428,000 | 5,529,000 | 5,482,000 | 5,680,000 |
| Inventories | 1,844,000 | 1,813,000 | 1,929,000 | 1,895,000 | 1,702,000 |
| TOTAL | $51,758,000 | $49,519,000 | $20,166,000 | $15,100,000 | $14,413,000 |
| Non-Current Assets | |||||
| PPE Net | 2,961,000 | 2,962,000 | 2,894,000 | 2,879,000 | 2,860,000 |
| Investments And Advances | 78,000 | 93,000 | 131,000 | 1,473,000 | 1,477,000 |
| Intangibles | 33,764,000 | 34,253,000 | 34,573,000 | 36,101,000 | 36,452,000 |
| Other Non-Current Assets | 2,638,000 | 2,288,000 | 1,677,000 | 1,589,000 | 1,567,000 |
| TOTAL | $39,441,000 | $39,596,000 | $39,275,000 | $42,042,000 | $42,356,000 |
| Total Assets | $91,199,000 | $89,115,000 | $59,441,000 | $57,142,000 | $56,769,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,762,000 | 3,753,000 | 5,276,000 | 5,641,000 | 2,078,000 |
| Accounts payable and accrued liabilities | 12,709,000 | 11,832,000 | 12,217,000 | 11,300,000 | 11,826,000 |
| TOTAL | $16,471,000 | $15,585,000 | $17,493,000 | $16,941,000 | $13,904,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 63,284,000 | 62,975,000 | 33,126,000 | 31,619,000 | 35,066,000 |
| Other Non-Current Liabilities | 17,900,000 | 17,597,000 | 15,990,000 | 16,000,000 | 14,509,000 |
| TOTAL | $82,143,000 | $81,702,000 | $50,174,000 | $48,767,000 | $50,691,000 |
| Total Liabilities | $98,614,000 | $97,287,000 | $67,667,000 | $65,708,000 | $64,595,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,476,742 | 1,479,157 | 1,478,821 | 1,478,484 | 1,478,332 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 5,973,000 | 4,717,000 | 3,673,000 | 3,384,000 | 4,234,000 |
| Other shareholders' equity | -3,697,000 | -3,596,000 | -2,528,000 | -2,491,000 | -2,516,000 |
| TOTAL | $-7,415,000 | $-8,172,000 | $-8,226,000 | $-8,566,000 | $-7,826,000 |
| Total Liabilities And Equity | $91,199,000 | $89,115,000 | $59,441,000 | $57,142,000 | $56,769,000 |